1,3-Dihydrospiro[benzo[d]imidazole-2,1'-cyclohexane]

Catalog No. :
ACCMAP865
CAS No. :
3190-03-2
Molecular Formula :
C12H16N2
Molecular Weight :
188.27

IUPAC Name:1,3-dihydrospiro[benzo[d]imidazole-2,1'-cyclohexane]

1,3-Dihydrospiro[benzo[d]imidazole-2,1'-cyclohexane] structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$294.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1,3-Dihydrospiro[benzo[d]imidazole-2,1'-cyclohexane]
IUPAC Name1,3-dihydrospiro[benzo[d]imidazole-2,1'-cyclohexane]
MDL No.MFCD00089091
Molecular FormulaC12H16N2
Molecular Weight188.27
SMILESC12=CC=CC=C1NC3(CCCCC3)N2
InChI KeyYWEQCYWQCBWFMN-UHFFFAOYSA-N
SynonymSPIRO[3-AZAINDOLINE-2,1'-CYCLOHEXANE];AKOS 90316;SPIRO(CYCLOHEXANE-1,2'-BENZIMIDAZOLINE);1,3-dihydrospiro[2H-benzimidazole-2,1'-cyclohexane];Spiro[2H-benzimidazole-2,1'-cyclohexane], 1,3-dihydro-;1,3-Dihydrospiro[benzo[d]imidazole-2,1'-cyclohexane;SPIRO(CYCLOHEXANE-1,2'-BENZIMIDAZOLINE)
CAS No.3190-03-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACCMAP865 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAWBD401 route compound structure diagram
    ACAWBD4017774-34-7 In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACCMAP865 route product structure diagram
    ACCMAP8653190-03-2
Inquiry

2. ACCMAP865 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCMAP865 route product structure diagram
    ACCMAP8653190-03-2
Inquiry

Comments (0)